LOPRIORE CHASE enters HEPION PHARMACEUTICALS, INC. with 1.25M shares — 100% direct ownership
Full direct ownership at entry is the strongest form of insider alignment with shareholders.
Direct
Filed: 5/26/2026ACC: 0001493152-26-025265
Director
Since Mar 2026
1.25M
Baseline shares
100% direct
1.25M
Direct ownership
1 position
0.00
Derivative underlying
0 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock, par value $0.0001 per share
DirectShares owned1.25M
Total
1.25M direct1.25M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock, par value $0.0001 per share | 1.25M | Direct |
| Total | 1.25M | 1.25M direct |
Derivative Holdings0
No derivative holdings reported